Literature DB >> 17303828

The cdx-hox pathway in hematopoietic stem cell formation from embryonic stem cells.

Claudia Lengerke1, Shannon McKinney-Freeman, Olaia Naveiras, Frank Yates, Yuan Wang, Dimple Bansal, George Q Daley.   

Abstract

Embryonic stem cells (ESCs) differentiated in vitro will yield a multitude of hematopoietic derivatives, yet progenitors displaying true stem cell activity remain difficult to obtain. Possible causes are a biased differentiation to primitive yolk sac-type hematopoiesis, and a variety of developmental or functional deficiencies. Recent studies in the zebrafish have identified the caudal homeobox transcription factors (cdx1/4) and posterior hox genes (hoxa9a, hoxb7a) as key regulators for blood formation during embryonic development. Activation of Cdx and Hox genes during the in vitro differentiation of mouse ESCs followed by co-culture on supportive stromal cells generates ESC-derived hematopoietic stem cells (HSCs) capable of multilineage repopulation of lethally irradiated adult mice. We show here that brief pulses of ectopic Cdx4 or HoxB4 expression are sufficient to enhance hematopoiesis during ESC differentiation, presumably by acting as developmental switches to activate posterior Hox genes. Insights into the role of the Cdx-Hox gene pathway during embryonic hematopoietic development in the zebrafish have allowed us to improve the derivation of repopulating HSCs from murine ESCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303828     DOI: 10.1196/annals.1392.006

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  A view of human haematopoietic development from the Petri dish.

Authors:  Andrea Ditadi; Christopher M Sturgeon; Gordon Keller
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-23       Impact factor: 94.444

2.  Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells.

Authors:  Stefan Irion; Raedun L Clarke; Hervé Luche; Injune Kim; Sean J Morrison; Hans-Joerg Fehling; Gordon M Keller
Journal:  Development       Date:  2010-07-21       Impact factor: 6.868

3.  Modeling murine yolk sac hematopoiesis with embryonic stem cell culture systems.

Authors:  Brandoch D Cook
Journal:  Front Biol (Beijing)       Date:  2014-10

4.  Hematopoietic development from human induced pluripotent stem cells.

Authors:  Claudia Lengerke; Matthias Grauer; Nina I Niebuhr; Tamara Riedt; Lothar Kanz; In-Hyun Park; George Q Daley
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

5.  Interactions between Cdx genes and retinoic acid modulate early cardiogenesis.

Authors:  Claudia Lengerke; Rebecca Wingert; Michael Beeretz; Matthias Grauer; Anne G Schmidt; Martina Konantz; George Q Daley; Alan J Davidson
Journal:  Dev Biol       Date:  2011-04-03       Impact factor: 3.582

Review 6.  Efforts to enhance blood stem cell engraftment: Recent insights from zebrafish hematopoiesis.

Authors:  Julie R Perlin; Anne L Robertson; Leonard I Zon
Journal:  J Exp Med       Date:  2017-08-22       Impact factor: 14.307

Review 7.  Cdx2 Animal Models Reveal Developmental Origins of Cancers.

Authors:  Kallayanee Chawengsaksophak
Journal:  Genes (Basel)       Date:  2019-11-14       Impact factor: 4.096

Review 8.  Caudal genes in blood development and leukemia.

Authors:  Claudia Lengerke; George Q Daley
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

Review 9.  Autologous blood cell therapies from pluripotent stem cells.

Authors:  Claudia Lengerke; George Q Daley
Journal:  Blood Rev       Date:  2009-11-11       Impact factor: 8.250

10.  A yeast one-hybrid and microfluidics-based pipeline to map mammalian gene regulatory networks.

Authors:  Carine Gubelmann; Sebastian M Waszak; Alina Isakova; Wiebke Holcombe; Korneel Hens; Antonina Iagovitina; Jean-Daniel Feuz; Sunil K Raghav; Jovan Simicevic; Bart Deplancke
Journal:  Mol Syst Biol       Date:  2013-08-06       Impact factor: 11.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.